Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID-19 severe or critically meta-analysis

Singh (TD-0903 10mg)
 
NCT04402866
RCTTD-0903 1mgCOVID-19 severe or criticallysome concern
6/6 ongoing
    Singh (TD-0903 1mg)
     
    NCT04402866
    RCTTD-0903placeboCOVID-19 severe or criticallysome concern
    6/6 inconclusive
      Singh (TD-0903 3mg)
       
      NCT04402866
      RCTTD-0903 3mgplaceboCOVID-19 severe or criticallysome concern
      7/6 inconclusive

        PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
        Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).